Biggest News Aggregation in the World
📰 Altimmune News

Page 2 - Altimmune News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Altimmune. Real-time updates on events, politics, business and more.

GSA Capital Partners LLP Grows Stake in Altimmune, Inc. (NASDAQ:ALT)

GSA Capital Partners LLP raised its stake in Altimmune, Inc. (NASDAQ:ALT – Free Report) by 153.1% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 445,868 shares of the company’s stock after purchasing an additional 269,676 shares during the quarter. GSA Capital […]
Goldman Sachs Group Charles Schwab Investment Management Inc Altimmune Company Profile Gsa Capital Partners Exchange Commission Investors Services

Altimmune (NASDAQ:ALT) Stock Rating Reaffirmed by B. Riley

B. Riley reissued their buy rating on shares of Altimmune (NASDAQ:ALT – Free Report) in a research note released on Tuesday morning, Benzinga reports. They currently have a $20.00 target price on the stock. A number of other brokerages have also weighed in on ALT. The Goldman Sachs Group started coverage on shares of Altimmune […]
United States Investment Advisers American International Group Inc Goldman Sachs Group Altimmune Inc Investors Services

WealthPlan Investment Management LLC Takes Position in Altimmune, Inc. (NASDAQ:ALT)

WealthPlan Investment Management LLC purchased a new position in Altimmune, Inc. (NASDAQ:ALT – Free Report) in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 11,931 shares of the company’s stock, valued at approximately $31,000. A number of other institutional investors and hedge funds also […]
Exchange Commission Altimmune Inc Wealthplan Investment Management Blackrock Inc Marshall Wace Nuveen Asset Management

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Altimmune (NASDAQ:ALT) Stock Price Up 5.8%

Altimmune, Inc. (NASDAQ:ALT – Get Free Report) was up 5.8% during trading on Tuesday . The company traded as high as $10.06 and last traded at $9.93. Approximately 926,426 shares changed hands during mid-day trading, a decline of 85% from the average daily volume of 6,349,605 shares. The stock had previously closed at $9.39. Wall […]
Brave Asset Management Inc Investment Advisers Wealthplan Investment Management Goldman Sachs Group Osaic Holdings Inc Altimmune Inc

Altimmune (NASDAQ:ALT) Stock Price Down 4.1%

Altimmune, Inc. (NASDAQ:ALT – Get Free Report)’s stock price fell 4.1% during trading on Wednesday . The company traded as low as $9.48 and last traded at $9.61. 1,232,811 shares changed hands during mid-day trading, a decline of 84% from the average session volume of 7,909,166 shares. The stock had previously closed at $10.02. Wall […]
Goldman Sachs Group Marshall Wace Balyasny Asset Management Geode Capital Management Blackrock Inc Altimmune Inc

The Goldman Sachs Group Begins Coverage on Altimmune (NASDAQ:ALT)

The Goldman Sachs Group assumed coverage on shares of Altimmune (NASDAQ:ALT – Free Report) in a report released on Wednesday, MarketBeat reports. The brokerage issued a neutral rating and a $13.00 price target on the stock. ALT has been the topic of a number of other research reports. HC Wainwright restated a buy rating and […]
Dekabank Deutsche Girozentrale Goldman Sachs Group Investment Advisors Connective Portfolio Management Horizon Wealth Management Investment Advisers
Source: wkrb13.com

Altimmune, Inc. (NASDAQ:ALT) to Post FY2028 Earnings of $0.26 Per Share, HC Wainwright Forecasts

Altimmune, Inc. (NASDAQ:ALT – Free Report) – Research analysts at HC Wainwright issued their FY2028 EPS estimates for shares of Altimmune in a report released on Friday, January 19th. HC Wainwright analyst P. Trucchio forecasts that the company will post earnings per share of $0.26 for the year. HC Wainwright currently has a “Buy” rating […]
Altimmune Inc Geode Capital Management Blackrock Inc Marshall Wace Balyasny Asset Management Free Report

Brokers Issue Forecasts for Altimmune, Inc.'s FY2028 Earnings (NASDAQ:ALT)

Altimmune, Inc. (NASDAQ:ALT – Free Report) – Stock analysts at HC Wainwright issued their FY2028 EPS estimates for shares of Altimmune in a note issued to investors on Friday, January 19th. HC Wainwright analyst P. Trucchio expects that the company will post earnings of $0.26 per share for the year. HC Wainwright currently has a […]
United States Allspring Global Investments Holdings American International Group Inc Altimmune Inc Altimmune Company Profile Sg Americas Securities

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science